Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-20

FDA Approved: FAMOTIDINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' Original Application for famotidine, a generic H2 blocker, enabling marketing for ulcers and gastroesophageal reflux disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)